In: Diabetologia, 2015, vol. 58, no. 8, p. 1827-1835
|
In: Diabetologia, 2015, vol. 58, no. 3, p. 456-463
|
In: Diabetologia, 2015, vol. 58, no. 2, p. 304-312
|
In: Human Molecular Genetics, 2017, vol. 26, no. 18, p. 3453-3465
|
In: Diabetologia, 2015, vol. 58, no. 2, p. 221-232
|
In: Journal of Molecular Medicine, 2015, vol. 93, no. 10, p. 1159-1169
|
In: Diabetologia, 2015, vol. 58, no. 3, p. 558-565
|
In: Shock, 2020, vol. 53, no. 5, p. 653–665
Objective: Activation of the constitutive nuclear and mitochondrial enzyme poly (ADP- ribose) polymerase (PARP) has been implicated in the pathogenesis of cell dysfunction, inflammation, and organ failure in various forms of critical illness. The objective of our study was to evaluate the efficacy and safety of the clinically approved PARP inhibitor olaparib in an experimental model of...
|
In: International Journal of Molecular Sciences, 2019, vol. 20, no. 21, p. 5391
Malignant mesothelioma (MM) is an aggressive asbestos-linked neoplasm, characterized by dysregulation of signaling pathways. Due to intrinsic or acquired chemoresistance, MM treatment options remain limited. Calretinin is a Ca2+-binding protein expressed during MM tumorigenesis that activates the FAK signaling pathway, promoting invasion and epithelial-to-mesenchymal transition. Constitutive...
|
In: Stem Cell Reports, 2019, vol. 13, no. 1, p. 1–9
Cancer stem cells (CSCs) are defined by their ability to regenerate a tumor upon transplantation. However, it is not yet clear whether tumors contain a single CSC population or different subsets of cells with mixed capacities for initiating primary and secondary tumors. Using two different identification strategies, we studied the overlap between metastatic stem cells and tumor-initiating...
|